Attached files

file filename
EX-32.1 - EX-32.1 - BRUKER CORPa2227490zex-32_1.htm
EX-31.2 - EX-31.2 - BRUKER CORPa2227490zex-31_2.htm
EX-21.1 - EX-21.1 - BRUKER CORPa2227490zex-21_1.htm
EX-31.1 - EX-31.1 - BRUKER CORPa2227490zex-31_1.htm
10-K - 10-K - BRUKER CORPa2227490z10-k.htm

QuickLinks -- Click here to rapidly navigate through this document


EXHIBIT 23.1

CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

        We consent to the incorporation by reference in the following Registration Statements:

    (1)
    Registration Statement (Form S-8, No. 333-167333) pertaining to the Bruker Corporation 2010 Incentive Compensation Plan,

    (2)
    Registration Statement (Form S-3, No. 333-159982) and related Prospectus of Bruker Corporation for the registration of 70,000,000 shares of its common stock, and

    (3)
    Registration Statements (Form S-8, Nos. 333-150430, 333-137090, 333-107294, and 333-47836) pertaining to the Bruker BioSciences Corporation Amended and Restated 2000 Stock Option Plan;

of our reports dated February 26, 2016, with respect to the consolidated financial statements of Bruker Corporation and the effectiveness of internal control over financial reporting of Bruker Corporation included in this Annual Report (Form 10-K) for the year ended December 31, 2015.

 
   
    /s/ Ernst & Young LLP

Boston, Massachusetts
February 26, 2016




QuickLinks

CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM